Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07503093 · ClinicalTrials.gov registry record · NA

Pilot Study of Sensor-Informed Smartphone-based Mental Health Interventions for Mood in Early Psychosis

A NA study, sponsored by Mclean Hospital.

Not yet
Registry status
NA
Development phase
10
Enrollment target

NCT07503093: Clinical Trial NA study, sponsored by Mclean Hospital.

NCT07503093 is a NA study that has not yet begun recruiting, run by Mclean Hospital. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07503093, a NA study, has not yet begun recruiting, sponsored by Mclean Hospital.

NOT YET RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target

Study Summary

The aim of this trial is to evaluate the feasibility and preliminary efficacy of using passive smartphone sensors to detect moments of heightened negative mood and inform the timing of brief mental health interventions, such as mindfulness exercises and psychoeducation, in adults with early psychosis.

Primary Outcome

Proportion of enrolled participants who completed the full 10 week study protocol, including both Phase 1 and Phase 2.

Interventions

  • BEHAVIORAL Smartphone-based Mindfulness Exercise
  • BEHAVIORAL Smartphone-based Psychoeducation
  • BEHAVIORAL Neutral Control Message

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2026-08-01
Est. Completion 2027-06-01
Phase NA
Mclean Hospital

140 total trials

What is known before NCT07503093 opens enrollment

NCT07503093 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 3 interventions - of which Smartphone-based Mindfulness Exercise is the first listed.

NCT07503093 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07503093 about?

NCT07503093 is a clinical study titled "Pilot Study of Sensor-Informed Smartphone-based Mental Health Interventions for Mood in Early Psychosis". The aim of this trial is to evaluate the feasibility and preliminary efficacy of using passive smartphone sensors to detect moments of heightened negative mood and inform the timing of brief mental health interventions, such as mindfulness exercises and psychoeducation, in adults with early psychosi...

What is the current status of trial NCT07503093?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2026-08-01. Estimated completion is 2027-06-01.

What interventions are being tested in trial NCT07503093?

The interventions under investigation include: Smartphone-based Mindfulness Exercise (BEHAVIORAL), Smartphone-based Psychoeducation (BEHAVIORAL), Neutral Control Message (BEHAVIORAL).

Who is sponsoring clinical trial NCT07503093?

This trial is sponsored by Mclean Hospital, which has 140 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07503093's enrollment target sits among peer trials

10 1927th of 2000 higher than 26 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07503093, the US trial registry maintained by the National Library of Medicine. NCT07503093 (small enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.